Association of high kinesiophobia and pain catastrophizing with quality of life in severe hip osteoarthritis: a cross-sectional study

Table 2 Differences in demographic and outcome characteristics of patients stratified by the level (high and low) of kinesiophobia and pain catastrophizing

	TSK-11 < 25 n = 35	TSK-11 ≥ 25 n = 56	P-value	PCS < 30 n = 60	PCS ≥ 30 n = 31	P-value
Age, years	65 (56–70)	66 (58–75)	0.37	65 (58–71)	66 (58–76)	0.52
Female sex, n (%)	33 (94)	43 (77)	0.04	51 (85)	25 (81)	0.77
BMI, kg/m ²	21.9 (19.9–24.9)	24.0 (21.4–26.9)	0.05	23.2 (20.9–26.3)	24.1 (21.1–26.5)	0.46
VAS	79 (62–86)	79.5 (65–88.8)	0.48	72.5 (60.8–85)	86 (79–93)	0.003
Smoking history, n (%)	6 (17)	10 (18)	0.93	12 (20)	4 (13)	0.56
JHEQ total	27 (18–34)	17.5 (12.3–26)	0.003	26 (17.3–34.8)	15 (6–22)	< 0.001
Pain	10 (5–12)	6 (3.3–12)	0.14	10 (6–12)	4 (2–7)	< 0.001
Movement	5 (2–9)	3 (1–7)	0.035	5 (2–9)	2 (0–5)	0.009
Mental	13 (9–16)	8 (5–11.8)	0.001	11.5 (8–15)	6 (3–9)	< 0.001
EQ-5D	0.649 (0.587–0.705)	0.587 (0.419–0.649)	0.009	0.649 (0.587–0.693)	0.533 (0.419–0.596)	< 0.001
TSK-11				24 (23–27)	28 (26–32)	< 0.001
PCS	21 (15–25)	29 (22–33.8)	< 0.001

Data are presented as medians (IQR). BMI, body mass index; EQ-5D, EuroQOL-5 Dimensions; IQR, interquartile range; JHEQ, Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire; PCS, pain catastrophizing scale; TSK, Tampa Scale for Kinesiophobia; VAS, visual analog scale

ISSN: 1471-2474